Iovance Biotherapeutics (IOVA) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Iovance Biotherapeutics (IOVA) over the last 7 years, with Q3 2025 value amounting to $1.2 million.
- Iovance Biotherapeutics' Interest & Investment Income fell 6896.38% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 3131.15%. This contributed to the annual value of $20.3 million for FY2024, which is 5543.2% up from last year.
- Per Iovance Biotherapeutics' latest filing, its Interest & Investment Income stood at $1.2 million for Q3 2025, which was down 6896.38% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Iovance Biotherapeutics' Interest & Investment Income registered a high of $9.6 million during Q4 2024, and its lowest value of $1.2 million during Q3 2025.
- In the last 3 years, Iovance Biotherapeutics' Interest & Investment Income had a median value of $3.4 million in 2024 and averaged $3.8 million.
- In the last 5 years, Iovance Biotherapeutics' Interest & Investment Income skyrocketed by 20708.79% in 2024 and then crashed by 6896.38% in 2025.
- Iovance Biotherapeutics' Interest & Investment Income (Quarter) stood at $3.1 million in 2023, then skyrocketed by 207.09% to $9.6 million in 2024, then plummeted by 87.02% to $1.2 million in 2025.
- Its last three reported values are $1.2 million in Q3 2025, $4.1 million for Q2 2025, and $3.2 million during Q1 2025.